Financial Results approved in the Board Meeting held on May 23, 2026.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Smallcap 250 and 2.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Rainbow Children's Medicare reported strong full-year results for FY2026. Consolidated revenue grew 12.4% year-on-year to ₹17,031 million, while profit after tax rose 15.3% to ₹2,815 million. The standalone PBT stood at ₹3,341 million. Auditors S.R. Batliboi & Associates LLP issued an unmodified opinion with no qualifications. The board recommended a final dividend of ₹3.5 per share (35% payout). An exceptional item of ₹15.39 million was recorded due to the New Labour Codes amendment increasing provisions for defined benefit obligations. The company also completed the acquisition of Prashanthi Medicare Private Limited (effective July 2025), contributing ₹191.5 million in revenue. All key directors including the Chairman & MD and Whole Time Director were reappointed for five-year terms.
Solid operational performance with consistent revenue and profit growth, clean audit with unmodified opinion, and shareholder-friendly dividend. No red flags from the auditors.